You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Optimus Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for OPTIMUS, and what generic and branded alternatives to OPTIMUS drugs are available?

OPTIMUS has two approved drugs.

There are two tentative approvals on OPTIMUS drugs.

Summary for Optimus
US Patents:0
Tradenames:2
Ingredients:2
NDAs:2
Patent Litigation for Optimus: See patent lawsuits for Optimus

Drugs and US Patents for Optimus

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Optimus BREXPIPRAZOLE brexpiprazole TABLET;ORAL 213758-001 Oct 25, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Optimus BREXPIPRAZOLE brexpiprazole TABLET;ORAL 213758-003 Oct 25, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Optimus AMINOCAPROIC ACID aminocaproic acid TABLET;ORAL 213944-001 Sep 14, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
Optimus BREXPIPRAZOLE brexpiprazole TABLET;ORAL 213758-006 Oct 25, 2023 AB RX No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.